Literature DB >> 3261664

Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.

L Matera1, R Foa, F Malavasi, G Bellone, A Funaro, F Veglia, D Santoli.   

Abstract

Freshly isolated B cells from chronic lymphocytic leukaemia patients (B-CLL) have been previously shown to induce a strong proliferative response and high levels of NK-like activity in lymphocytes from healthy donors. The present paper deals with the origin, mitotic state, target spectrum and cell surface phenotype of the NK-like effectors generated after stimulation with B-CLL. Experiments using large granular lymphocytes (LGL) and T cells as responders demonstrated that most of the precursors of the newly generated NK-like effectors express the CD3 antigen. The induction of NK-like activity paralleled cell activation, as judged by blast transformation, thymidine uptake and appearance of cell surface activation markers. The newly generated NK-like effectors displayed a T cell phenotype and a broader target repertoire than native NK cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261664      PMCID: PMC1541532     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes.

Authors:  A Poros; E Klein
Journal:  Cell Immunol       Date:  1979-08       Impact factor: 4.868

2.  Generation of non MHC restricted killing in non-cytotoxic T-lymphocytes from leukaemia patients.

Authors:  L Matera; E Cardoso; L Caudana; M Moore
Journal:  Br J Haematol       Date:  1987-02       Impact factor: 6.998

3.  Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.

Authors:  G Strassmann; F H Bach; J M Zarling
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

4.  Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.

Authors:  M López-Botet; A Silva; J Rodríguez; M O de Landazuri
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  H D Kay; D A Horwitz
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

6.  Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells.

Authors:  P K Pattengale; M Gidlund; K Nilsson; C Sundström; J Sällström; B Simonsson; H Wigzell
Journal:  Int J Cancer       Date:  1982-01-15       Impact factor: 7.396

7.  Characterization of HNK-1+ (Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells.

Authors:  T Abo; C M Balch
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

8.  Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity.

Authors:  J R Ortaldo; G D Bonnard; P D Kind; R B Herberman
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

9.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  1 in total

1.  B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.

Authors:  L Matera; R Foa; M Massaia; M Giovarelli; F Veglia; A Cesano; P Lusso; A Piazza; D Santoli
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.